Putting brakes on insulin pump infusion to prevent hypoglycemia.
4
TL;DR: The author provides an analysis of the study published by Agrawal and colleagues, which describes usage and effectiveness of the low glucose suspend feature that is integrated into the Medtronic Paradigm Veo™ sensor-augmented pump system.
read more
Abstract: The author provides an analysis of the study published by Agrawal and colleagues, in this issue of Journal of Diabetes Science and Technology, which describes usage and effectiveness of the low glucose suspend feature that is integrated into the Medtronic Paradigm® Veo™ sensor-augmented pump system.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Automated Insulin Delivery in Children with Type 1 Diabetes.
Eda Cengiz,Eda Cengiz +1 more
TL;DR: Evidence from AID studies conducted in children with type 1 diabetes are summarized and the outlook for future generation AID systems from a pediatric treatment perspective is discussed.
9
Long‐term Outcomes after Islet Transplantation
A. M. James Shapiro,Camillo Ricordi +1 more
- 25 Jul 2014
4
Effectiveness of the low-glucose suspend feature of insulin pump during fasting during Ramadan in type 1 diabetes mellitus.
TL;DR: This prospective study investigated the effect of the low‐glucose suspend (LGS) algorithm on the frequency of hypoglycaemia in adolescents with T1DM who wished to fast during Ramadan.
References
Continuous glucose monitoring and intensive treatment of type 1 diabetes.
William V. Tamborlane,Roy W. Beck,Bruce W. Bode,Bruce A. Buckingham,Chase Hp,Robert Clemons,Rosanna Fiallo-Scharer,Larry A. Fox,Lisa K. Gilliam,Irl B. Hirsch,Elbert S. Huang,Kollman C,Kowalski Aj,Lori M.B. Laffel,Jean M. Lawrence,Joyce M. Lee,Nelly Mauras,Michael J. O'Grady,Katrina J. Ruedy,Michael Tansey,Eva Tsalikian,Stuart A. Weinzimer,Darrell M. Wilson,Howard Wolpert,T. Wysocki,Dongyuan Xing +25 more
TL;DR: Continuous glucose monitoring can be associated with improved glycemic control in adults with type 1 diabetes and further work is needed to identify barriers to effectiveness of continuous monitoring in children and adolescents.
1.4K
•Journal Article
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes
Roy W. Beck,Irl B. Hirsch,Lori M. Laffel,William V. Tamborlane,Bruce W. Bode,Bruce A. Buckingham,H. Peter Chase,Robert Clemons,Rosanna Fiallo-Scharer,Larry A. Fox,Lisa K. Gilliam,Elbert S. Huang,Craig Kollman,Aaron J. Kowalski,Jean M. Lawrence,Joyce M. Lee,Nelly Mauras,Michael J. O'Grady,Katrina J. Ruedy,Michael Tansey,Eva Tsalikian,Stuart A. Weinzimer,Darrell M. Wilson,Howard Wolpert,Tim Wysocki,Dongyuan Xing +25 more
TL;DR: In this paper, the authors compared a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.
249
Usage and Effectiveness of the Low Glucose Suspend Feature of the Medtronic Paradigm Veo Insulin Pump
TL;DR: Use of the LGS feature significantly reduced exposure to hypoglycemia in patients using the Medtronic Paradigm Veo™ pump with automatic low glucose suspend, and this feature was on for most of the patient days in the study.
Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy.
Thomas Danne,Olga Kordonouri,Martin Holder,Holger Haberland,Sven Golembowski,K Remus,Sara Bläsig,T Wadien,Susanne Zierow,Reinhard Hartmann,Andreas Thomas +10 more
TL;DR: Evidence is provided that SAP with LGS reduces the frequency of hypoglycemia without compromising safety, and no episodes of severe hyperglycemia or diabetic ketoacidosis were observed following LGS activation.